Related Experiment Videos
Plasmocytoma (a study of 222 cases)
Italian Journal of Orthopaedics and Traumatology
|December 1, 1978
Summary
Solitary plasmocytoma is not rare and presents distinct bone localization compared to multiple myeloma. Prognosis depends on lesion count, bloodwork, paraprotein levels, and for solitary cases, patient sex and tumor site.
Area of Science:
- Oncology
- Hematology
Background:
- Plasmocytoma, a plasma cell neoplasm, can manifest as solitary or multiple lesions.
- Understanding the distinct characteristics and prognostic factors of solitary plasmocytoma is crucial for effective management.
Purpose of the Study:
- To analyze the characteristics and prognostic indicators of solitary plasmocytoma in comparison to multiple myeloma.
- To evaluate the efficacy of radiotherapy combined with Malphalan as a treatment for plasmocytoma.
Main Methods:
- Review of 222 cases of plasmocytoma.
- Analysis of prognostic factors including number of lesions, anemia, calcemia, hypoalbuminemia, paraprotein levels, patient sex, and primary localization.
- Assessment of treatment outcomes for radiotherapy and Malphalan.
Main Results:
- Solitary plasmocytoma is not rare and exhibits different bone localization than multiple myeloma.
- Prognosis is influenced by lesion number, anemia, calcemia, hypoalbuminemia, and paraprotein type/level.
- For solitary plasmocytoma, sex and primary site also impact prognosis.
- Elevated proteinaemia occurred in 40% of cases; electrophoresis was negative in 20%.
Conclusions:
- Solitary plasmocytoma requires distinct consideration from multiple myeloma due to differing localization and prognostic factors.
- Radiotherapy combined with Malphalan is the recommended treatment approach for plasmocytoma.